Current diagnosis and treatment of pancreatic cancer in China.
about
Alisertib induces cell cycle arrest and autophagy and suppresses epithelial-to-mesenchymal transition involving PI3K/Akt/mTOR and sirtuin 1-mediated signaling pathways in human pancreatic cancer cellsDirect in vivo injection of 131I-GMS and its distribution and excretion in rabbitKnockdown of OCT4 suppresses the growth and invasion of pancreatic cancer cells through inhibition of the AKT pathwayOverexpression of GOLPH3 is associated with poor prognosis and clinical progression in pancreatic ductal adenocarcinoma.HERG1 functions as an oncogene in pancreatic cancer and is downregulated by miR-96.Construction of targeted plasmid vector pcDNA3.1-Egr.1p-p16 and its expression in pancreatic cancer JF305 cells induced by radiation in vitroNet expression inhibits the growth of pancreatic ductal adenocarcinoma cell PL45 in vitro and in vivoPlumbagin induces cell cycle arrest and autophagy and suppresses epithelial to mesenchymal transition involving PI3K/Akt/mTOR-mediated pathway in human pancreatic cancer cells.Low expression of TBX4 predicts poor prognosis in patients with stage II pancreatic ductal adenocarcinoma.Dickkopf3 overexpression inhibits pancreatic cancer cell growth in vitroPolymorphisms in UGT2B4 and susceptibility to pancreatic cancer.Paracrine SDF-1α signaling mediates the effects of PSCs on GEM chemoresistance through an IL-6 autocrine loop in pancreatic cancer cells.Recurrent TERT promoter mutations identified in a large-scale study of multiple tumour types are associated with increased TERT expression and telomerase activation.ABO blood type, diabetes and risk of gastrointestinal cancer in northern China.On pancreatic cancer screening by magnetic resonance imaging with the recent evidence by Del Chiaro and colleagues.MicroRNA-375 targets the 3-phosphoinositide-dependent protein kinase-1 gene in pancreatic carcinomaThe status of HBV infection influences metastatic pattern and survival in Chinese patients with pancreatic cancer.Expression levels of microRNA-375 in pancreatic cancer.Downregulation of L1CAM inhibits proliferation, invasion and arrests cell cycle progression in pancreatic cancer cells in vitroKnockdown of PFTK1 inhibits tumor cell proliferation, invasion and epithelial-to-mesenchymal transition in pancreatic cancer.MiR-125a regulates chemo-sensitivity to gemcitabine in human pancreatic cancer cells through targeting A20.Identification of cystatin SN as a novel biomarker for pancreatic cancer.Parthenolide suppresses pancreatic cell growth by autophagy-mediated apoptosis.Bufalin exerts antitumor effects by inducing cell cycle arrest and triggering apoptosis in pancreatic cancer cells.MicroRNA-424-5p suppresses the expression of SOCS6 in pancreatic cancer.MicroRNA 483-3p suppresses the expression of DPC4/Smad4 in pancreatic cancer.MicroRNA-196b inhibits late apoptosis of pancreatic cancer cells by targeting CADM1.Expression and clinical significance of complement C3, complement C4b1 and apolipoprotein E in pancreatic cancer.Targeted Co-delivery of PTX and TR3 siRNA by PTP Peptide Modified Dendrimer for the Treatment of Pancreatic Cancer.CTNND1 755 T>G Promoter Polymorphism and Risk of Pancreatic Carcinoma in Chinese.
P2860
Q28386389-BBFE19E5-1DBB-45E8-ABE0-6612F483C4DDQ33830713-456847FE-8E71-467B-B6B0-80AF2B05875DQ34000656-1FA5E799-F08A-480F-A37F-72181BEB8943Q34048461-46B8DCF8-E96C-4C44-AAD3-E8947E226226Q34221680-0FB5E441-5795-4011-8F90-69BBD8EE435CQ34604821-F83FA5C0-D2EE-474F-82CF-44747AF222E3Q34612458-79B667A5-B501-4CBC-9315-FA6E5F331674Q35006343-D42B16D1-9AF2-469E-88D9-1D2278E9ADBDQ35229461-EDE54F26-D3BA-43D4-8A10-1BF21D25512CQ35235941-A5096E2E-B2DC-40AB-9D3F-2DDCD6CE1D67Q35481132-2EB0459D-EEDD-4C90-912F-2A80B356B43EQ35550177-A52F4B2D-0B2A-4F1A-B2C9-935DAAD31393Q35743608-D2681975-0F1F-4F39-BA9D-C2517E572910Q35759631-21FB3ED5-2A79-4230-B5F4-55C9C6170432Q36029939-D086A58F-9E27-48AB-87B5-EAE91F835E67Q37229396-09D7B44C-92EE-4397-A184-60278BD14575Q37365328-6DB5DFD7-DDAE-4239-A9AA-61E645C51B42Q37565518-D6EA7CBD-0C4E-4F6E-83CF-D0DD66C25BD9Q37652158-783658B4-ED82-426C-9FC1-CAA22FDFC8CBQ38798475-A8D5B6AE-B60A-430A-9B59-09B9F92C3568Q38804384-7F404654-28EB-4900-A437-21C188BE0DDDQ38921259-4026A0BD-3393-46A6-81E4-EB52A9A724B4Q38972618-EE1749DD-281E-4BDC-86A5-C13EA9F34024Q39064254-B4238028-9171-45D1-AEA1-90A1CCD67CC9Q39154906-BEAAEDC7-C316-49E3-A1BC-BF0C023D94A9Q39626698-5A933D48-181F-4089-9CA2-4E8E5CA44E51Q41127121-43FE56C3-B9BB-4CB8-90C2-DD4FFD3E0190Q42553545-428113F2-14F8-46C0-9D74-FD73D825A99AQ51131993-FCD0EDA5-58B8-483C-B5B1-5EA2BA1F5656Q51548347-0D1C62B4-5866-4970-8D52-F0494398D0C7
P2860
Current diagnosis and treatment of pancreatic cancer in China.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
2005年论文
@zh
2005年论文
@zh-cn
name
Current diagnosis and treatment of pancreatic cancer in China.
@ast
Current diagnosis and treatment of pancreatic cancer in China.
@en
type
label
Current diagnosis and treatment of pancreatic cancer in China.
@ast
Current diagnosis and treatment of pancreatic cancer in China.
@en
prefLabel
Current diagnosis and treatment of pancreatic cancer in China.
@ast
Current diagnosis and treatment of pancreatic cancer in China.
@en
P1433
P1476
Current diagnosis and treatment of pancreatic cancer in China.
@en
P2093
Xiaozhong Guo
Zhongmin Cui
P356
10.1097/01.MPA.0000168220.97967.D1
P577
2005-07-01T00:00:00Z